Sophia Genetics (Sophia Genetics) Additional Paid-In Capital : $472.03 Mil(As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Sophia Genetics Additional Paid-In Capital?

Sophia Genetics's quarterly additional paid-in capital increased from Sep. 2023 ($471.83 Mil) to Dec. 2023 ($471.85 Mil) and increased from Dec. 2023 ($471.85 Mil) to Mar. 2024 ($472.03 Mil).

Sophia Genetics's annual additional paid-in capital increased from Dec. 2021 ($470.89 Mil) to Dec. 2022 ($471.62 Mil) and increased from Dec. 2022 ($471.62 Mil) to Dec. 2023 ($471.85 Mil).

Sophia Genetics Additional Paid-In Capital Historical Data

The historical data trend for Sophia Genetics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sophia Genetics Additional Paid-In Capital Chart

Sophia Genetics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

119.23

227.43

470.89

471.62

471.85

Sophia Genetics Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial													471.77	471.83	471.83	471.85	472.03

Sophia Genetics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Sophia Genetics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sophia Genetics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Sophia Genetics (Sophia Genetics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sophia Genetics SA (NAS:SOPH) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

90B:Germany

Address

Rue du Centre 172, Saint-Sulpice, CHE, CH-1025

Website

https://www.sophiagenetics.com

Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities.